Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic
Sign Up to like & getrecommendations! Published in 2023 at "Oncoimmunology"
DOI: 10.1080/2162402x.2023.2197370
Abstract: ABSTRACT BO-112 is a poly I:C-based viral mimetic that exerts anti-tumor efficacy when intratumorally delivered in mouse models. Intratumoral BO-112 synergizes in mice with systemic anti-PD-1 mAbs and this combination has attained efficacy in PD1-refractory… read more here.
Keywords: intratumoral neoadjuvant; anti tumor; neoadjuvant immunotherapy; tumor efficacy ... See more keywords